Showing results (261-270 of 269) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 269 results.
Blood Advances|June 8, 2022
Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphomaAnthony R Colombo, Monirath Hav, Mohan Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2022
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial CarcinomaSarmad Sadeghi, David Quinn, Tanya Dorff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2023
Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib TrialSteffan T Nawrocki, Julian Olea, Claudia Villa Celi, et al.
Journal of Medicinal Chemistry|April 19, 2019
Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of ObesityAjeet Kumar, Venkata Reddy Pasam, Ravi Kumar Thakur, et al.
Oncology|April 20, 2023
Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory StudyDerek H Liu, Komal A Dani, Sharath S Reddy, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2026
Pretransplant Blinatumomab Is Associated With Reduced Relapse and Improved Disease-Free Survival in Adults With B-Cell ALL Undergoing Allogeneic Hematopoietic Cell TransplantationAnush A Ginosyan, Karam Ashouri, Tiffany Chen, et al.
EMBO Reports|December 18, 2024
Salmonella Typhimurium effector SseI regulates host peroxisomal dynamics to acquire lysosomal cholesterolDesh Raj, Abhilash Vijay Nair, Anmol Singh, et al.
Molecular Endocrinology (Baltimore, Md.)|April 16, 2011
Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor αShailendra Kumar Dhar Dwivedi, Nidhi Singh, Rashmi Kumari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with GuadecitabineCasey L O'Connell, Maria R Baer, Andreas Due Ørskov, et al.
Pageof 27